NIAID Banner Logo Image

HIV Citation List: August 17 - August 30, 2012

PubMed citations

1. A Multi-functional Peptide as an HIV-1 Entry Inhibitor Based on Self-concentration, Recognition, and Covalent Attachment. Zhao, L., P. Tong, Y.X. Chen, Z.W. Hu, K. Wang, Y.N. Zhang, D.S. Zhao, L.F. Cai, K.L. Liu, Y.F. Zhao, and Y.M. Li. Organic & Biomolecular Chemistry, 2012. 10(32): p. 6512-6520. PMID[22760295].

[PubMed].HIV_0817-083012.

2. Design, Synthesis, and Preclinical Evaluations of Novel 4-Substituted 1,5-diarylanilines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) Drug Candidates. Sun, L.Q., L. Zhu, K. Qian, B. Qin, L. Huang, C.H. Chen, K.H. Lee, and L. Xie. Journal of Medicinal Chemistry, 2012. 55(16): p. 7219-7229. PMID[22856541]

[PubMed].HIV_0817-083012.

3. Stereoselective Synthesis and Antiviral Activity of Methyl-substituted cycloSal-pronucleotides. Rios Morales, E.H., J. Balzarini, and C. Meier. Journal of Medicinal Chemistry, 2012. 55(16): p. 7245-7252. PMID[22827702].

[PubMed].HIV_0817-083012.

4. Stereoselective Synthesis of D- and L-carbocyclic nucleosides by Enzymatically Catalyzed Kinetic Resolution. Mahler, M., B. Reichardt, P. Hartjen, J. van Lunzen, and C. Meier. Chemistry, 2012. 18(35): p. 11046-11062. PMID[22829408]

[PubMed].HIV_0817-083012.

5. CXCR4-Tropic, but Not CCR5-tropic, Human Immunodeficiency Virus Infection is Inhibited by the Lipid Raft-associated Factors, Acyclic Retinoid Analogs, and Cholera Toxin B Subunit. Kamiyama, H., K. Kakoki, S. Shigematsu, M. Izumida, Y. Yashima, Y. Tanaka, H. Hayashi, T. Matsuyama, H. Sato, N. Yamamoto, T. Sano, Y. Shidoji, and Y. Kubo. AIDS Research and Human Retroviruses, 2012. [Epub ahead of print]; PMID[22845664].

[PubMed].HIV_0817-083012.

6. New anti-HIV Aptamers Based on Tetra-end-linked DNA G-quadruplexes: Effect of the Base Sequence on anti-HIV Activity. D'Atri, V., G. Oliviero, J. Amato, N. Borbone, S. D'Errico, L. Mayol, V. Piccialli, S. Haider, B. Hoorelbeke, J. Balzarini, and G. Piccialli. Chemical Communications, 2012. 48(76): p. 9516-9518. PMID[22898884]

[PubMed].HIV_0817-083012.

7. A Novel Synthetic Bivalent Ligand to Probe Chemokine Receptor CXCR4 Dimerization and Inhibit HIV-1 Entry. Choi, W.T., K.S. Kumar, N. Madani, X. Han, S. Tian, C.Z. Dong, D. Liu, S. Duggineni, J. Yuan, J.G. Sodroski, Z. Huang, and J. An. Biochemistry, 2012. [Epub ahead of print]; PMID[22897429].

[PubMed].HIV_0817-083012.

8. Lentiviral Gene Therapy against HIV-1 Using a Novel Human TRIM21-CyclophilinA Restriction Factor. Chan, E., T. Schaller, A. Eddaoudi, H. Zhan, C.P. Tan, M. Jacobsen, A. Thrasher, G.J. Towers, and W. Qasim. Human Gene Therapy, 2012. [Epub ahead of print]; PMID[22909012].

[PubMed].HIV_0817-083012.

9. Emtricitabine Prodrugs with Improved anti-HIV Activity and Cellular Uptake. Agarwal, H.K., B.S. Chhikara, S. Bhavaraju, D. Mandal, G.F. Doncel, and K. Parang. Molecular Pharmaceutics, 2012. [Epub ahead of print]; PMID[22917277]

[PubMed].HIV_0817-083012.

ISI Web of Knowledge Citations

10. One Pot Synthesis of Structurally Different Mono and Dimeric Ni(II) thiosemicarbazone Complexes and N-Arylation on a Coordinated Ligand: A Comparative Biological Study. Prabhakaran, R., P. Kalaivani, P. Poornima, F. Dallemer, G. Paramaguru, V.V. Padma, R. Renganathan, R. Huang, and K. Natarajan. Dalton Transactions, 2012. 41(31): p. 9323-9336. ISI[000306523100011].

[WOS]. HIV_0817-083012.

11. Enamino-oxindole HIV Protease Inhibitors. Eissenstat, M., T. Guerassina, S. Gulnik, E. Afonina, A.M. Silva, D. Ludtke, H. Yokoe, B. Yu, and J. Erickson. Bioorganic & Medicinal Chemistry Letters, 2012. 22(15): p. 5078-5083. ISI[000306481100033].

[WOS]. HIV_0817-083012.

12. Algal Lectins as Potential HIV Microbicide Candidates. Huskens, D. and D. Schols. Marine Drugs, 2012. 10(7): p. 1476-1497. ISI[000306749000005].

[WOS]. HIV_0817-083012

13. Synthesis and Study of 2-(Pyrrolesulfonylmethyl)-N-arylimines: A New Class of Inhibitors for Human Glutathione Transferase A1-1. Koutsoumpli, G.E., V.D. Dimaki, T.N. Thireou, E.E. Eliopoulos, N.E. Labrou, G.I. Varvounis, and Y.D. Conis. Journal of Medicinal Chemistry, 2012. 55(15): p. 6802-6813. ISI[000307264100013].

[WOS]. HIV_0817-083012

14. New Nitrogen Containing Substituents at the Indole-2-carboxamide Yield High Potent and Broad Spectrum Indolylarylsulfone HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. La Regina, G., A. Coluccia, A. Brancale, F. Piscitelli, V. Famiglini, S. Cosconati, G. Maga, A. Samuele, E. Gonzalez, B. Clotet, D. Schols, J.A. Este, E. Novellino, and R. Silvestri. Journal of Medicinal Chemistry, 2012. 55(14): p. 6634-6638. ISI[000306764600035].

[WOS]. HIV_0817-083012

15. Antiviral Inhibition of the HIV-1 Matrix Protein. Mercredi, P., P. Bhargava, and M. Summers. Protein Science, 2012. 21: p. 154-155. ISI[000307019800256].

[WOS]. HIV_0817-083012

16. Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme. Singh, N., A. Ranjan, S. Sur, R. Chandra, and V. Tandon. Journal of Biosciences, 2012. 37(3): p. 493-502. ISI[000306588100010].

[WOS]. HIV_0817-083012

17. The Hematopoietic Cell-Specific Rho GTPase Inhibitor ARHGDIB/D4GDI Limits HIV Type 1 Replication. Watanabe, T., E. Urano, K. Miyauchi, R. Ichikawa, M. Hamatake, N. Misawa, K. Sato, H. Ebina, Y. Koyanagi, and J. Komano. Aids Research and Human Retroviruses, 2012. 28(8): p. 913-922. ISI[000306683600026].

[WOS]. HIV_0817-083012

Patent citations

18. 2-Hydroxyisoquinoline-1,3(2H,4H)-diones and Related Compounds as HIV Integrase Inhibitors and Their Preparation and Use for the Treatment of HIV Infection and AIDS. Bailly, F., M. Billamboz, F. Christ, P. Cotelle, Z. Debyser, C. Lion, and V. Suchaud. Patent. 2012. 2011-EP73480 2012085003: 165pp.

[Patent]. HIV_0817-083012.

19. Proline-rich Antiviral Peptides for Treatment, Prevention and Eradication of HIV Infection. Cabras, T., C. Casoli, M. Castagnola, R. Inzitari, R. Longhi, I. Messana, P. Ronzi, and A. Vitali. Patent. 2012. 2012-IB50421 2012101617: 48pp.

[Patent]. HIV_0817-083012.

20. Preparation of Schizandrin C Analogs as Antiviral Drugs. Chang, J., C. Song, and Q. Yang. Patent. 2012. 2012-10029643

102603836: 28pp.

[Patent]. HIV_0817-083012.

21. Preparation of Raltegravir-Chelator Derivatives as HIV Integrase Inhibitors. Cohen, S. M., A. Agrawal, J. Desoto, Y. Pommier, and K. Maddali. Patent. 2012. 2012-US23662 2012106534: 115pp.

[Patent]. HIV_0817-083012.

22. Preparation of Isoquinoline Compounds and Methods for Treating HIV. De La Rosa, M. A., S. N. Haydar, B. A. Johns, and E. Johann Velthuisen. Patent. 2012. 2012-US22161 2012102985: 243pp.

[Patent]. HIV_0817-083012.

23. Stabilized Therapeutic Small Helical Antiviral Peptides for Treatment of HIV Infection. Debnath, A. K., H. Zhang, and Q. Zhao. Patent. 2012. 2012-364667 20120165249: 35pp.

[Patent]. HIV_0817-083012.

24. Fused 6,5 Bicyclic Ring System P2 Ligands, and Methods for Treating HIV. Ghosh, A. K. Patent. 2012. 2011-US67112 2012092168: 71pp.

[Patent]. HIV_0817-083012.

25. Compositions Containing HIV Protease Inhibitors for Treatment of HIV Infection. Ghosh, A. K. Patent. 2012. 2011-US67160 2012092188: 52pp.

[Patent]. HIV_0817-083012.

26. Preparation of 1,2,3-Triazole Derivatives as HIV-1 Integrase Inhibitors. Hu, L., X. He, J. Hu, Z. Luo, S. Zhang, and C. Zeng. Patent. 2012. 2011-10302075 102503900: 19pp.

[Patent]. HIV_0817-083012.

27. Modulators of Viral Transcription, and Methods and Compositions Therewith. Kashanchi, F. Patent. 2012. 2011-329721 20120149708: 58pp.

[Patent]. HIV_0817-083012.

28. An Antibacterial and Antiviral Compound Isolated from Marine Actinomycete. Kumar, V., M. Doble, B. Ramasamy, S. Ganesan, R. Manikkam, L. E. Hanna, S. Swaminathan, and S. Nagamiah. Patent. 2012. 2012-IB50463 2012104793: 39pp.

[Patent]. HIV_0817-083012.

29. Preparation of Isosorbide Derivatives as HIV-1 Protease Inhibitors. Liu, Z. and X. Qiu. Patent. 2012. 2012-10140535 102627654: 9pp.

[Patent]. HIV_0817-083012.

30. Nucleic acid Binding Compounds as anti-HIV Agents. Miller, B. L., L. O. Ofori, and A. V. Gromova. Patent. 2012. 2011-US67576 2012092367: 128pp.

[Patent]. HIV_0817-083012.

31. Functionalized Nucleic acids and Particles Comprising Them for the Treatment of HIV Infections. Mouscadet, J. F., O. Delelis, F. Subra, G. Divita, T. Zatsepin, Y. Agapkina, and M. Gottikh. Patent. 2012. 2010-195020 2468303: 43pp.

[Patent]. HIV_0817-083012.

32. Preparation of C28 Amines of C3 Modified Betulinic Acid Derivatives as HIV Maturation Inhibitors. Regueiro-Ren, Alicia, Jacob Swidorski, Sing-Yuen Sit, Yan Chen, Jie Chen, Nicholas A. Meanwell, and Zheng Liu. Patent. 2012. 2012-US22847 2012106188: 305pp.

[Patent]. HIV_0817-083012.

33. Compounds Useful for Treating AIDS. Tazi, Jamal, Florence Mahuteau, Romain Najman, Didier Scherrer, Noeelie Campos, and Aude Garcel. Patent. 2012. 2011-IB55643 2012080953: 73pp.

[Patent]. HIV_0817-083012.

34. Preparation of Pyrimidoazepines as HIV Integrase Inhibitors Useful in the Treatment of HIV Infection and AIDS. Ueda, Yasutsugu, Timothy P. Connolly, Barry L. Johnson, Chen Li, B. Narasimhulu Naidu, Manoj Patel, Kevin Peese, Margaret E. Sorenson, Michael A. Walker, Michael S. Bowsher, and Rongti Li. Patent. 2012. 2011-US63874 2012078834: 293pp.

[Patent]. HIV_0817-083012.

If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: May 2022